Industry News
Food standards body calls for comment on cost recovery
Food Standards Australia New Zealand (FSANZ) invites comments on consultation papers it has released on proposed cost recovery arrangements for health claims applications. [ + ]
UNE scientist wins Young Tall Poppy Award
Dr Paul McDonald, a lecturer in animal behaviour at the University of New England, has been honoured with one of this year’s Young Tall Poppy Science Awards for NSW. [ + ]
Nanomedicine breakthrough improves chemotherapy for childhood cancer
In a world first, researchers from The University of New South Wales’ (UNSW) Australian Centre for NanoMedicine (ACN) have developed a nanoparticle that improves the effectiveness of chemotherapy for neuroblastoma by a factor of five. [ + ]
Getting to the heart of Prader-Willi Syndrome
Researchers at the Garvan Institute have found a sign that the rare genetic disorder, Prader-Willi Syndrome, is linked to problems in the autonomic nervous system. [ + ]
Mesoblast reaffirms Teva partnership following share slump
Mesoblast (ASX:MSB) has reassured shareholders of the strength of its partnership with Teva Pharmaceutical Industries after rumours circulated that Teva may exit the stem cell collaboration. [ + ]
Free pathology tests app launched for patients and doctors
Patients and their doctors can now get up-to-date information about pathology testing on their smartphones whenever and wherever they need it. [ + ]
LCT wins ethics nod for NZ Ntcell trial
Living Cell Technologies (ASX:LCT) has secured ethics approval for the first in-human trial of its Ntcell treatment in patients with Parkinson's disease. [ + ]
Possible link between immune system and Alzheimer’s
An international research team, including scientists from the University of Toronto’s (U of T) Faculty of Medicine, has discovered a link between a mutation in an immune system gene and Alzheimer’s disease. [ + ]
Sir Gus Nossal and Ita Buttrose receive gongs at Research Australia Awards
Australia’s leading health and medical researchers and advocates have been recognised in the Research Australia Awards. [ + ]
Australian Life Scientists acquired by specialist laboratory publisher
Australian Life Scientist magazine, and its sister website www.lifescientist.com.au, have been acquired by Westwick-Farrow Media (WFM), and will join its stable of B2B magazines and websites, including What’s New in Lab & Life Sciences. [ + ]
AmpliPhi and SPS complete merger
Australia's Special Phage Services is now part of US-based AmpliPhi, following the closure of a merger between the two bacteriophage companies. [ + ]
New project to support life sciences boards and directors
AusBiotech, with support from the Victorian Government, has begun a project to support board and directors’ development and promote best practice reporting and governance. [ + ]
Australian Life Scientist acquired by specialist laboratory publisher
Australian Life Scientist magazine and its website have been acquired by Westwick-Farrow Media and will join its stable of B2B magazines and websites, including What’s New in Lab & Life Sciences (est 1990), www.labonline.com.au and What’s New in Food Technology & Manufacturing. [ + ]
A risk gene for cannabis psychosis
Recent research has implicated a variation in the gene that codes for a protein called RAC-alpha serine/threonine-protein kinase (Akt1) in the risk for cannabis psychosis. [ + ]
Funding difficulties see Avexa turn to mining
Avexa (ASX:AVX) is committing most of its cash to an investment in a US coal mine to generate cash for development of its clinical programs including HIV drug ATC. [ + ]
